prednisolone has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " JLSG-02 was modified from JLSG-96 as follows: increased prednisolone dosage at the induction phase and extension of maintenance therapy duration from 24 to 48 weeks." | 2.87 | Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group- ( Goto, H; Imamura, T; Imashuku, S; Kawaguchi, H; Kitoh, T; Kosaka, Y; Kudo, K; Morimoto, A; Shioda, Y; Tsunematsu, Y, 2018) |
| "The mechanism of neuropathology in MPS IIIB is unclear." | 1.35 | Innate and adaptive immune activation in the brain of MPS IIIB mouse model. ( Auer, H; Best, V; Charrier, A; DiRosario, J; Divers, E; Etter, J; Fu, H; Jukkola, P; McCarty, DM; Newsom, DL; Wang, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morimoto, A | 1 |
| Shioda, Y | 1 |
| Imamura, T | 1 |
| Kudo, K | 1 |
| Kitoh, T | 1 |
| Kawaguchi, H | 1 |
| Goto, H | 1 |
| Kosaka, Y | 1 |
| Tsunematsu, Y | 1 |
| Imashuku, S | 1 |
| DiRosario, J | 1 |
| Divers, E | 1 |
| Wang, C | 1 |
| Etter, J | 1 |
| Charrier, A | 1 |
| Jukkola, P | 1 |
| Auer, H | 1 |
| Best, V | 1 |
| Newsom, DL | 1 |
| McCarty, DM | 1 |
| Fu, H | 1 |
| Schneider, A | 1 |
| Araújo, GW | 1 |
| Trajkovic, K | 1 |
| Herrmann, MM | 1 |
| Merkler, D | 1 |
| Mandelkow, EM | 1 |
| Weissert, R | 1 |
| Simons, M | 1 |
1 trial available for prednisolone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-
Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Diabetes Insipidus; Female; Follow-Up Studies; | 2018 |
2 other studies available for prednisolone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Innate and adaptive immune activation in the brain of MPS IIIB mouse model.
Topics: Animals; Astrocytes; Autoantibodies; Brain; Demyelinating Diseases; Disease Models, Animal; Disease | 2009 |
Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis.
Topics: Animals; Blotting, Western; Brain; Cells, Cultured; Cuprizone; Cyclin-Dependent Kinase 5; Cyclin-Dep | 2004 |